Evolución clínica de 31 pacientes adultos con trombocitopenia inmune tratados con rituximab

BACKGROUND: Primary immune thrombocytopenia (ITP) is an autoimmune disease that could cause different grades of bleeding, which could even threat the patients’ life or make them experience poor quality of life. ITP can be treated with rituximab either as a first or second-line therapy option, result...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez-Espíndola, Guillermo Rodolfo, Medrano-Contreras, Jesús, Campa-Monroy, Dafne Itzel, Sabbagh-Sánchez, Elizabeth, Martínez-Castro, Raúl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Mexicano del Seguro Social 2023
Materias:
Aportación Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395956/
https://www.ncbi.nlm.nih.gov/pubmed/36542424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395956/
https://www.ncbi.nlm.nih.gov/pubmed/36542424

Ejemplares similares